Author name: Leonardo Arias

From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing

The shift from ex vivo to in vivo gene delivery is rewriting the rules of viral vector manufacturing, forcing developers to rethink scale, purity, cell lines and analytics as vectors themselves become the drug. AGC Biologics is betting on stable producer lines, next‑gen purification and deeper characterization to meet the far stricter demands of in […]

From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing Read More »

Scroll to Top